We are thrilled to share that RV Invest has made an investment in Diagonal Therapeutics, a biotech startup pioneering a new approach to discovering and developing agonist antibodies.
The Cambridge-based biotech is led by industry veteran Alexey “Alex” Lugovskoy and cofounded by Atlas Venture. We are excited to join Diagonal Tx investors and support the company in advancing their early-stage pipeline as well as their lead candidate, DIAG723, for the treatment of hereditary hemorrhagic telangiectasia, a severe bleeding disorder.